Edgestream Partners L.P. Buys Shares of 90,026 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Edgestream Partners L.P. bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 90,026 shares of the company’s stock, valued at approximately $3,570,000.

Several other large investors have also recently bought and sold shares of ACHC. Lindbrook Capital LLC increased its stake in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares during the last quarter. Fifth Third Bancorp grew its stake in shares of Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock worth $50,000 after purchasing an additional 454 shares during the last quarter. Finally, Covestor Ltd grew its stake in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $30.57 on Friday. Acadia Healthcare Company, Inc. has a one year low of $28.09 and a one year high of $84.44. The company has a 50-day moving average of $41.32 and a two-hundred day moving average of $50.24. The stock has a market cap of $2.84 billion, a price-to-earnings ratio of 10.02, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ACHC shares. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. KeyCorp lowered their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, March 3rd. Royal Bank of Canada lowered their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $56.31.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.